Found: 13
ОБЗОР2026 · pp. 79–86
Ivanova E.I., Chernyshova A.L., Sisakyan V.G., Tamkovich S.N.
Relevance. PARP inhibitors (PARPi), have emerged as a significant development in the treatment of high-grade serous ovarian cancer that is associated with mutations in BRCA1/2 and genes of other homologous recombination proteins. These drugs exploit synthetic …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 52–56
Kaigorodova E.V., Kovalеv O.I., Grishchenko M.Y., Tulendinov E.R.
Introduction. Ovarian cancer is characterized by high mortality. Despite available diagnostic and therapeutic methods, patient survival remains unsatisfactory, especially for high-grade tumors, necessitating the exploration of new molecular targets. Heat shock…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Fatkhutdinov N.R., Zhang R., Kiyamova R.G.
Introduction. Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer characterized by frequent mutations in the ARID1A gene and low sensitivity to standard-of-care chemotherapeutic agents. The aim of the study. To determine the role of A…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2019
Aliyev J.А., Melikova L.A., Mansurov E.B., Aliyeva F.K., Bagirova E.E., Mexdizade S.Q., Nadjafova A.S.
Introduction. Breast cancer is the leading cancer type among woman of Azerbaijan population. Hereditary mutations of the BRCA1/2 genes are considered as high risk for appeared breast and ovarian cancers. In Azerbaijan BRCA1/2-related breast and ovarian cancer …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Zlatnik E.Yu., Nerodo G.A., Novikova I.A., Bakhtin A.V., Zakora G.I., Selyutina O.N., Ardzha A.Yu.
Introduction. Immunologic microenvironment of malignant tumors is likely to be significant in «tumor-host» interaction. The aim of the study. Сomparative analysis of systemic and local factors of cellular and humoral immunity in patients with ascitic forms of …
ОБЗОР2016
Gershtein E.S., Kushlinsky D.N., Adamyan L.V., Kushlinskii N.E.
MicroRNAs (miRNAs) – small non-coding RNAs targeting multiple mRNAs – are posttranscriptional regulators of gene expression involved in carcinogenesis, metastasis, and invasion. MiRNAs expression is altered in various human tumors including ovarian cancer. Ana…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Yunusova N.V., Kondakova I.V., Kolomiets L.A., Villert A.B.
Introduction: Insulin-like growth factors (IGFs), insulin-like growth factor-I receptor (IGF-IR), IGR-binding proteins (IGFBPs) and IGBP proteases can play an important role in the development of metastases in ovarian cancer. The relationship between IGF syste…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Shirshova A.N., Aushev V.N, Filipenko M.L., Kushlinskii N.E.
The most important event in the molecular biology of the last years is the discovery of the regulation of intracellular processes by micro RNAs – a product of complicated processing of precursor RNAs synthesized on nuclear genes, that are playing the key role …
Research article2014
Gershtein E.S., Isaeva E.R., Kushlinsky D.N., Korotkova E.A., Ermilova V.D., Laktionov K.P., Adamyan L.V.
Introduction. Insulin-like growth factor signaling system plays a major role in the development and progression of various malignant tumors including ovarian cancer, and its components are considered as potential diagnostic and prognostic markers and objects o…
Research article2013
Kushlinsky D.N., Tereshkina I.V., Degtiyar V.G., Laktionov K.P., Adamyan L.V.
A literature review is devoted to the analysis of clinical significance of key factors of neoangiogenesis in ovarian cancer patients, their connection with the main clinical and morphological characteristics of the disease, prognosis, features an anti-angiogen…
Research article2013
Afanasyeva N.A., Khvostova E.P., Pustyl’nyak V.O., Chasovnikova O.B., Krasil’nikov S.E., Gulyaeva L.F.
Early diagnosis of ovarian cancer (OC) remains to be the actual problem in modern oncology due to the high mortality rate, asymptomatic course of the disease in the early stages and its aggressiveness. The aim was to study the genetic polymorphism of pathogene…
Research article2013
Gershtein E.S., Kushlinsky D.N., Adamyan L.V., Tereshkina I.V., Laktionov K.P.
Publications devoted to the role of various representatives of matrix metalloproteinases (MMPs) family and their tissue inhibitors in ovarian cancer in differential diagnostics, prognosis and in the development of new treatment modalities are critically analyz…
Research article2013
Manukhin I.B., Sharashenidze O.A., Ermilova V.D., Kryuk Yu.V., Kostyleva O.I.
Results of radioligand determination of epidermal growth factor receptor (EGFR) and radioreceptor assessment of EGF-like peptides’ (EGFLP) levels in the tumors of 44 ovarian cancer and 10 benign ovarian tumor patients are presented. Frequency of revelation and…